57% of Seniors Protected From Seasonal Flu

The weekly National Immunization Survey (NIS) findings were published today, providing an update on the receipt of vaccination and intent for COVID-19, RSV, and influenza vaccination.

The NIS vaccination trend estimates increased as of November 13, 2023, are as follows:

The percent of the population reporting receipt of a flu vaccine is 32.6% (30.7-5%) for children and 34.8% (33.2-36.3%) for adults 18+, including 57.6% (53.7-61.5%) among adults 65+.

The percent of the population reporting receipt of the updated 2023-24 COVID-19 vaccine is 4.9% (95% confidence interval: 3.6-1%) for children and 13.9% (12.8-15.0%) for adults 18+, including 30.4% (26.9-33.9%) among adults 65+.

The percent of adults 60+ that report receiving an RSV vaccine is 13.5% (11.4-15.6%).

The U.S. CDC recommends that everyone six months and older stay current on COVID-19 and seasonal flu vaccines.

If you are 60 years and older, talk to your healthcare provider to see if RSV vaccination is proper for you.

The CDC also recommends Beyfortus™ (nirsevimab), a single-injection, monoclonal antibody product, providing passive immunization for all infants younger than eight months who are born during or entering their first RSV season and some older toddlers.